4//SEC Filing
Stephan Dietrich A 4
Accession 0001104659-22-007324
CIK 0001173281other
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 1:50 PM ET
Size
5.7 KB
Accession
0001104659-22-007324
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Award
Employee Stock option (right to buy)
2022-01-24+306,000→ 306,000 totalExercise: $1.58Exp: 2032-01-24→ Common Stock (306,000 underlying)
Footnotes (1)
- [F1]25% of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.
Documents
Issuer
NeuBase Therapeutics, Inc.
CIK 0001173281
Entity typeother
Related Parties
1- filerCIK 0001774588
Filing Metadata
- Form type
- 4
- Filed
- Jan 24, 7:00 PM ET
- Accepted
- Jan 25, 1:50 PM ET
- Size
- 5.7 KB